EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. (IST:ECILC)

Market Cap	30.10B
Revenue (ttm)	6.05B
Net Income (ttm)	2.87B
Shares Out	685.26M
EPS (ttm)	4.20
PE Ratio	10.47
Forward PE	n/a
Dividend	1.18 (2.69%)
Ex-Dividend Date	Jun 5, 2024

Volume	2,552,542
Average Volume	2,026,041
Open	44.02
Previous Close	43.92
Day's Range	43.02 - 44.44
52-Week Range	37.20 - 64.80
Beta	-0.10
RSI	49.86
Earnings Date	Feb 24, 2025

About IST:ECILC

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses in Turkey and internationally. The Health segment produces and sells human health and veterinary medicines, as well as engages in pharmaceutical sales and marketing. Its Real Estate Development segment develops real estate properties; engages in leasing activities for serum facilities; and provides consulting services on land development and project management. The company was incorporate...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1951
• Employees: 1,144
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: ECILC

Financial Performance

In 2023, IST:ECILC's revenue was 6.48 billion, an increase of 86.94% compared to the previous year's 3.47 billion. Earnings were 2.74 billion, a decrease of -8.16%.